SA
MYGN icon

Sanctuary Advisors’s Myriad Genetics MYGN Stock Holding History

Sanctuary Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,720
Closed -$92K – 2522
2025
Q3 		$92K Sell
12,720
-12,143
-49% -$72.1K ﹤0.01% 2357
2025
Q2 		$132K Buy
24,863
+2,643
+12% +$15.6K ﹤0.01% 2235
2025
Q1 		$197K Sell
22,220
-50
-0.2% -$601 ﹤0.01% 2042
2024
Q4 		$288K Buy
22,270
+96
+0.4% +$1.77K ﹤0.01% 2026
2024
Q3 		$343K Buy
22,174
+206
+0.9% +$5.58K ﹤0.01% 1919
2024
Q2 		$399K Buy
+21,968
New +$482K ﹤0.01% 1786

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sanctuary Advisors's MYGN Position: Q4 2025 in Review

Sanctuary Advisors sold out of Myriad Genetics (MYGN) in Q4 2025, closing a stake of 12,720 shares — an estimated $92K sold.

Sanctuary Advisors first reported a position in MYGN in Q2 2024 and held it in 6 quarters. The position peaked at $399K in Q2 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2025.

  • Sanctuary Advisors reported no remaining Myriad Genetics position as of Q4 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 12,720 Myriad Genetics shares in Q4 2025, an estimated $92K.
  • Sanctuary Advisors first reported a position in Myriad Genetics in Q2 2024 and held it in 6 quarters.
  • Sanctuary Advisors's Myriad Genetics position peaked at $399K in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2025.

Based on Sanctuary Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.